1-[5-(DIMETHYLAMINO)-NAPHTHALENE-1-SULFONYL]-4-(2-METHYLPROPYL)-PYRROLIDIN-2-ONE
Compound with spectra: 1 NMR
![1-[5-(DIMETHYLAMINO)-NAPHTHALENE-1-SULFONYL]-4-(2-METHYLPROPYL)-PYRROLIDIN-2-ONE](/api/compound/FyMzR7Ovzwq.png?ph=true&h=300&w=458 "1-[5-(DIMETHYLAMINO)-NAPHTHALENE-1-SULFONYL]-4-(2-METHYLPROPYL)-PYRROLIDIN-2-ONE")
| SpectraBase Compound ID | FyMzR7Ovzwq |
|---|---|
| InChI | InChI=1S/C20H26N2O3S/c1-14(2)11-15-12-20(23)22(13-15)26(24,25)19-10-6-7-16-17(19)8-5-9-18(16)21(3)4/h5-10,14-15H,11-13H2,1-4H3 |
| InChIKey | ZNZQCPYUWHWHGF-UHFFFAOYSA-N |
| Mol Weight | 374.5 g/mol |
| Molecular Formula | C20H26N2O3S |
| Exact Mass | 374.166414 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-(2-Naphthalenemethyl)-5-dimethylaminonaphthalene-N-propyl-1-sulfonamide
N-[4-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-ylmethyl)piperazin-1-yl]-(5-dimethylamino)-1-naphthalenesulfonamide radical
N-dansyl N-methyl-methylthreonine
Dimethyl N-dansyl-N-methylglutamate
1-Naphthalenesulfonamide, 5-(dibutylamino)-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-
N-dansyl-methyltyrosine
4-[2-(([5-(Dimethylamino)-1-naphthyl]sulfonyl)amino)propyl]phenyl 5-(dimethylamino)-1-naphthalenesulfonate
1-Naphthalenesulfonic acid, 5-(dimethylamino)-, 4-[2-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-1-hydroxyethyl]phenyl ester
1-Naphthalenesulfonic acid, 5-(dimethylamino)-, 4-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl ester
1-Naphthalenesulfonamide, 5-(dimethylamino)-N-[4-[2-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]ethyl]phenyl]-
| Title | Journal or Book | Year |
|---|---|---|
| Separation and characterization of modified pregabalins in terms of cyclodextrin complexation, using capillary electrophoresis and nuclear magnetic resonance | Journal of Pharmaceutical and Biomedical Analysis | 2010 |